US$ 21.73
dihexa nephrotoxicity after radionuclide therapies Sub-2.5-nm amidoxime metal-organic frameworks alleviate
Description
Some individuals may continue experiencing appetite-related effects during this period

On this page

In September 2025, the agency issued over 50 warning letters to companies selling GLP-1 products (including retatrutide) with marketing that implied human use

In the USA, figures from 2008 show that 33 million musculoskeletal injuries are reported per year, with 50% involving ligament and tendon injuries (James et al
